Frederic H Moll bought $785K of PROCEPT BioRobotics (PRCT)
Executed Aug 13 2025, disclosed Aug 14 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Aug 14 2025), the stock returned -7.0% (delay-adjusted); from the execution session (Aug 13 2025), +0.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
Frederic H Moll (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in SSII. Across 1 priced purchase filing, the average 21-session return was -0.4% from execution and -6.3% from disclosure (delay-adjusted; derived). The largest single filing was $2.0M of SSII (501,253 sh × $3.99, as filed), executed Mar 6.
Healthcare · PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and interna…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→